Jessica Oswald, MD
Pain Medicine · San Diego, CANPI 1427315118
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $69,117 of the $89,893 with a category attached, or 76.9%. Vertex accounts for 67.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $42,813 and has fallen 62.7% since, to $15,986 in 2025. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 113 payments — averaging $795.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$61K
- GRT US Holding, Inc.$18K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$8K
- Abbott$1K
- Boston Scientific$726
- SPR Therapeutics, Inc$327
- plus $753 from 9 others
What the payments were for
- Consulting fees$69,11777%
- Speaking & faculty fees$7,6298%
- Travel & lodging$7,9599%
- Food & beverage$4,8515%
- Education$1940%
- Entertainment$1420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 45 | $60,902 |
| GRT US Holding, Inc. | 17 | $18,259 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $7,709 |
| Abbott | 14 | $1,218 |
| Boston Scientific | 7 | $726 |
| SPR Therapeutics, Inc | 6 | $327 |
| Vertiflex, Inc. | 3 | $199 |
| Averitas Pharma Inc. | 1 | $198 |
| Bioness Inc | 1 | $142 |
| Vertos Medical, Inc. | 1 | $62 |
| Nevro Corp. | 2 | $48 |
| Merz North America, Inc. | 1 | $35 |
| Avanos Medical | 1 | $33 |
| Medtronic | 1 | $20 |
| Ambu Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Qutenza$18,292
- XIFAXAN$7,409
- JOURNAVX$1,957
- Proclaim Family of SCS IPGs$608
- GENERAL PAIN MANAGEMENT$287
- GENERAL - THERAPIES$156
- SPRINT PNS System$146
- Stimrouter for pain$142
- Proclaim IPG$136
- Superion ISS$112
How this compares
$89,893 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclobenzaprine Hcl | 20 | $404 |
| Gabapentin | 14 | $173 |
| Celecoxib | 13 | $89 |
| Meloxicam | 11 | $7 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in San Diego
- Nathaniel SchusterSan Diego$337K
- Mark WallaceSan Diego$221K
- Gemayel LeeSan Diego$131K
- Zachary CohenSan Diego$36K
- Joel CastellanosSan Diego$30K
- David HillerSan Diego$30K
- Seth KatzenSan Diego$29K
- Jason PopeSanta Rosa$2.1M
- Ramana NaiduLarkspur$1.4M
- Foead GeulaStudio City$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.